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Abstract
Objective: Green Fluorescent Protein (GFP) has been used as a marker of gene expression and a single cell marker in living
organisms in cell biology studies. The important areas that GFP is used are expression levels of different genes in different
organisms by inserting GFP in these genes and as a marker in living cells. In this study, we tried to optimize transfection of
mesenchymal stem cells, (MSCs) used for regeneration of damaged tissues in animals, by GFP containing plasmid vector by
which MSCs can be followed in vivo. 
Material and Methods: To this aim, phM-GFP plasmid vector carrying GFP gene and effectene transfection reagent were used.
Result: The data revealed that twice transfection of MSCs resulted in higher expression of GFP for longer times as compared
to once transfected MSCs. On the other hand, leaving the chemical transfection agents in the medium induced apoptosis
after a while. 
Conclusion: As a conclusion we suggest the transfection of MSCs twice with 48 hours interval and removal of transfection
agents after 8 hours which removed toxic and apoptotic effects of the chemicals. (Turk J Hematol 2008; 25: 172-5)
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Özet
Amaç: Yeflil floresan proteini (YFP), günümüzde hücre biyolojisi çal›flmalar›nda tan›mlay›c› gen ve hücre iflaretleyici olarak kul-
lan›lmaktad›r. YFP’nin oldukça önemli kullan›m alanlar› farkl› genlerin içerisine eklenerek bu genlerin farkl› organizmalardaki
ekspresyonlar›n›n miktar tayininde ve canl› hücreler içerisinde iflaretleyici olarak kullan›labilmesidir. Bu çal›flmam›zda doku tamiri
amac›yla ve hayvanlara aktard›¤›m›z mezankimal kök hücrelerini (MKH) in vivo takip edebilmek amac› ile YFP genini içeren
plazmid vektörünün MKH’lara aktar›lmas›n› optimize etmeye çal›flt›k.
Yöntem ve Gereçler: Bu amaçla YFP geni tafl›yan phM-YFP plazmid vektörü ve MKH’lara plazmid vektörün aktar›lmas› amac›
ile Effectene Transfeksiyon kiti kullan›lm›flt›r. 
Bulgular: Elde edilen sonuçlar, MKH’lar›n phM-YFP ile iki defa transfekte edilmelerinin tek bir defa transfekte edilmelerine göre
daha yüksek oranda ve daha uzun süreli YFP ekspresyonu sa¤lad›¤›n› göstermifltir. 
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Introduction
Stem cells have the ability to differentiate into different types
of cells and to self-renew [1] and thus can be used for the gen-
eration of replacement tissue for damaged tissues and organs.
They can be transplanted for the efficient treatment of diabetes
[2], Parkinson’s disease [3], and heart disease [4]. Adult stem
cells can be obtained from the patient’s own cells, maintained in
cell culture and then given back to the patient [5]. 
Besides hematopoietic stem cells (HSCs), bone marrow
(BM) contains a different cell population that plays important
roles in hematopoiesis, known as mesenchymal stem cells
(MSCs) or marrow stromal cells. They are composed of
endothelial cells, adipocytes, osteoblasts and fibroblasts. MSCs
are multipotent precursors present in adult BM, having the abili-
ty to differentiate into osteoblasts, adipocytes, chondrocytes,
tenocytes, and myoblasts [6,7]. Although MSCs represent a very
small fraction of the total population of nucleated cells in the
marrow (0.01%-0.001%) [6], they can easily be separated from
the HSCs by their ability to adhere to glasses and plastics [8].
They can maintain an undifferentiated and stable phenotype over
many generations in vitro. MSCs are found in the fetal BM and
liver and adult BM and peripheral blood [9].
Having the ability to migrate towards and engraft at sites of
damage, in vivo, MSCs elicit a regenerative effect on the injured
tissue. This multi-potentiality, their ease of isolation and high
capacity for in vitro expansion drew considerable interest in their
use in tissue engineering, in vitro and in vivo functional studies,
and therapeutic trials [10].
This activity underpins the strong interest in the therapeutic
use of MSCs in different diseases. Nevertheless, there are sev-
eral questions related to the applications of MSCs that should be
addressed. Very limited data are available related to the final fate
of systemically infused MSC. Pereira and his co-workers
showed in rodents that MSCs have a broad initial biodistribution
followed by a limited capacity for sustained engraftment [11].
Parallel with this result, Liechty and co-workers showed that
MSCs have undergone a wide tissue distribution and can differ-
entiate into multiple mesenchymal tissues following peritoneal
implantation in fetal sheep [12]. One of the ways to follow the
MSCs is to mark them with green fluorescence protein (GFP).
GFP is commonly used for monitoring gene expression, protein
trafficking within intact cells and pursuing the transfected cells.
GFP can easily be visualized by standard fluorescence
microscopy to track real-time subcellular localization of a protein
of interest.
Transfection is a method commonly used to insert plasmid
DNAs, RNAs, siRNAs, and miRNAs into eukaryotic cells. As the
cells were transfected with foreign molecules, these molecules
could be expressed transiently or permanently. Permanent
transfection is generally preferred, since the transferred genetic
material is inserted into the genome. A great number of methods
and reagents exist, including physical (microinjection, electropo-
ration), chemical (calcium phosphate, DEAE-Dextran), lipophilic
(liposomes), and viral (retroviruses) methods [13-16]. In our
study, we preferred effectene transfection reagent, since it
shows low toxicity and provides transfection of small amounts of
DNA, while the transfection procedure could be performed in the
complete medium [17].
In this study, we tried to optimize transfection of MSCs with
GFP containing phGFP vector and then examined the fate of
MSCs both in vitro and in vivo. 
Materials and Methods
Bone Marrow Harvest: The New Zealand rabbits were sedat-
ed with ketamine (35 mg/kg intramuscular) and were anesthetized
with sevoflurane (3% to 8%). The iliac crest area was prepared and
draped using sterile technique and approximately 5 ml of BM was
aspirated into a syringe containing 3000 units of heparin.
Isolation and Culture of MSCs: Between 10 and 15x106
whole marrow cells were placed in a 75 cm2 tissue culture flask
in Dulbecco’s modified Eagle’s medium (DMEM; Biological
Industries, Israel). After 72 hours (h), the nonadherent cells were
removed by changing the medium. The medium was complete-
ly replaced every 3 days, and the nonadherent cells were dis-
carded. Cultured MSCs were observed under inverted micro-
scope to assess the level of expansion and to verify the morphol-
ogy at each culture medium change. To prevent the MSCs from
differentiating or slowing their rate of division, each primary cul-
ture was replaced (first passage) to 3 new plates when the cell
density within colonies became 80% to 90% confluent, approx-
imately 2 weeks after seeding. The adherent cells were released
from dishes with 0.25% trypsin in 1 mmol/L sodium ethylenedi-
aminetetraacetic acid (EDTA, Sigma, St. Louis, MO, USA), split
1:3, and seeded onto fresh plates. After the twice-passaged
cells became nearly confluent, they were harvested and used for
the experiments. We demonstrated with these adherence cells
after three-passage as excluding hematopoietic markers (CD34-
and CD45-) and expressing stromal markers (CD73+ and
CD105+) in human MSCs. In addition, we also performed
osteogenic differentiation with osteogenic media of rabbit MSCs.
Medium: The cells were routinely cultured in complete medi-
um consisting of DMEM containing selected lots of 10% fetal calf
serum (FCS), 2 mmol/L L-glutamine, 100 U/ml of penicillin G and
100 μg/ml of streptomycin (Biological Industries, Israel) at 37°C
in a humidified atmosphere of 5% carbon dioxide. 
Transfection of MSCs by GFP: MSCs grown in 75 cm2
flask were detached by trypsin-EDTA treatment and replated in
25 cm2 at a density of 1x106 cells in 5 ml of complete media.
Sonuç: MKH’lar›n YFP ile iflaretlenmesi çal›flmalar›nda transfeksiyon kimyasallar›n›n yeterli bir inkübasyondan sonra
uzaklaflt›r›lmas›n›n ve transfeksiyon iflleminin 48 saat arayla iki defa yap›lmas›n›n MKH’lar›n aktar›ld›¤› doku veya canl›larda daha
uzun süreli ve daha etkin bir flekilde takibine olanak sa¤layaca¤› gösterilmifltir. (Turk J Hematol 2008; 25: 172-5)
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Transfection of MSCs with Monster Green Fluorescent Protein
(phMGFP) Vector system (Promega) was conducted using
Effectene Transfection Reagent (Qiagen). Transfection was per-
formed as described by the manufacturer. 
Briefly, the cells were split the day before transfection to
maintain the viability. On the day of transfection, the cells were
harvested by centrifugation, the supernatant was removed and
the cells were washed once with PBS in a 15 ml Falcon tube.
About 1x106 cells were seeded per 60 mm dish in 4 ml growth
medium containing serum and antibiotics.
The day before transfection, 5x105 cells were seeded per 60
mm dish in 5 ml appropriate growth medium containing serum
and antibiotics. The cells were incubated under their normal
growth conditions (37°C and 5% CO2). The day of transfection,
1 μg DNA was diluted with the DNA-condensation buffer, Buffer
EC, to a total volume of 150 μl. 8 μl Enhancer was added and
mixed by vortexing for 1s. This mixture was incubated at room
temperature (25°C) for 5 min and then was spinned down for a
few seconds to remove drops from the top of the tube. 25 μl
Effectene Transfection Reagent was added to the DNA-
enhancer mixture and was mixed by vortexing for 10s. The sam-
ples were incubated for 10 min at room temperature (25°C) to
allow transfection-complex formation. While complex formation
was in process, the growth medium was gently aspirated from
the plate, and the cells were washed once with 4 ml PBS. 4 ml
fresh growth medium (can contain serum and antibiotics) was
added on to the cells. 1 ml growth medium (can contain serum
and antibiotics) was added to the tube containing the transfec-
tion complexes. The samples were mixed by pipetting up and
down twice, and immediately were added on to the transfection
complexes drop-wise onto the cells in the 60 mm dishes. The
dish was gently swirled to ensure uniform distribution of the
transfection complexes. 
Each experiment was conducted three times. The light den-
sity was obtained by fluorescent microscope and the light den-
sity of the cells was compared between two once- and twice-
transfected cells for the different time points.
Results
The cells were successfully grown in DMEM containing
selected lots of 10% FCS, 2 mmol/L L-glutamine, 100 U/ml of
penicillin G and 100 μg/ml of streptomycin at 37°C in 5% carbon
dioxide for the first passage (Figure 1), and attached MSCs
(Figure 2) were selected while the suspension hematopoietic
stem cells were discarded.
At the beginning of the transfection experiments, the trans-
fection chemicals were not removed from the media, which
resulted in apoptosis after 72 h on the cells, which were alive and
attached to the surface. Later, chemical agents were removed
from the media after 8 h, the cells were washed, and the media
was refreshed. It was determined that this method significantly
prevented apoptosis after 72 h incubation of cells. 
In order to optimize higher expression levels of GFP in the
long-term, we conducted two parallel experiments. In the first
group, the transfection was performed once (Figure 3), while for
the second group the transfection procedure was performed
twice (Figure 4), with a 48-h interval. After transfections, both
groups of cells were incubated for 48-, 96-, 144- and 216 h in
CO2 incubator, and the fluorescent light density was examined
under fluorescent microscope. The results revealed that, after 48
h of incubation (Figure 3A), the first group of cells reflected fluo-
rescent green light. However, the light density was low as com-
pared to light density of incubated cells reflected after 96- (Figure
3B), 144- (Figure 3C), and 216 h (Figure 3D) (p<0.05, p<0.05
and p<0.01). Twice-transfected cells also reflected higher fluo-
rescent light density after 48 h (Figure 4A) as compared to once-
transfected cells. The light density of the second group was also
increased in parallel to increasing time from 48 h to 96 (Figure
4B), 168 (Figure 4C) and 216 h (Figure 4D) (p<0.05). 
Discussion
Marking of stem cells is a widely used strategy to follow stem
cells in living animals and cells. There are a number of ways to
follow cells in living organisms, including microinjection, electro-
poration, calcium phosphate precipitation, DEAE-Dextran, lipo-
somes and adenoviruses, lentiviruses, and retroviruses [13-16].
It was clearly shown by Meier and coworkers that effectene
transfection method has low toxicity and better transfection effi-
ciency in neuronal cells [17]. One other important property of
effectene transfection reagent is its ability to work in the com-
plete medium [17].
Tomiyama and coworkers in 2007 used the same strategy to
characterize BM cells in adipose tissue in the rat [18]. Our data
revealed that MSCs transfected twice with GFP vector with 48 h
time interval exhibited higher expression of GFP and reflected
much more fluorescent light density for a longer time as com-
pared to once-transfected MSCs. Removing the chemical
agents used for the transfection of MSCs inhibited apoptosis
resulting from the cytotoxic effects of the transfection agents.
These results give vital data regarding how to conduct transfec-
tion to follow MSCs transferred to tissues and living organisms.
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Figure 1. Micrograph of mesenchymal stem cells maintained in DMEM
media for (A) 3 and (B) 5 days
Figure 2. Micrograph of mesenchymal stem cells after (A) 2nd and(B) 3rd
passage
1A 1B
2A 2B
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Figure 3. Micrographs of once-transfected mesenchymal stem cells incubat-
ed for (A) 48-, (B) 96-, (C) 144-, and (D) 216 hours p<0,05, p<0,05 and p<0,01
Figure 4. Micrographs of twice-transfected mesenchymal stem cells incu-
bated for (A) 48-, (B) 96-, (C) 144- and (D) 216 hours p<0,05
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